U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

RECOMBINANT HUMAN SERUM ALBUMIN ORYZA SATIVA WHOLE

MORE DETAILS

YW8K2QSC5N

structurally diverse
Status:
Investigational
Source:
NCT04384523: Phase 1 Interventional Completed Ascites Hepatic
(2019)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT04384523
Class:
STRUCTURALLY DIVERSE

ORYZA GLABERRIMA WHOLE

MORE DETAILS

M7A88DTA98

structurally diverse
Status:
Other
Class:
STRUCTURALLY DIVERSE

ORYZA SATIVA WHOLE

MORE DETAILS

84IVV0906Z

structurally diverse
Status:
Possibly Marketed Outside US
Source:
PiGe ll Real Skin Neck Pack by Osung Co., Ltd
(2013)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a04fe02-16af-4dd1-8e12-cc9e64f9bfce
First approved in 2013
Source:
PiGe ll Real Skin Neck Pack by Osung Co., Ltd
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a04fe02-16af-4dd1-8e12-cc9e64f9bfce
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966